Robert J Lederman

Title: Innovations by Robert J Lederman in Atherosclerosis Detection

Introduction

Robert J Lederman is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical technology, particularly in the detection of atherosclerosis. His innovative approach combines the use of radioactive tracers with advanced detection devices to improve patient outcomes.

Latest Patents

Lederman holds a patent for a method titled "Method for detecting early atherosclerosis and vascular damage using radioactive tracers and intravascular radiation detection devices." This patent describes a method and apparatus designed to detect and optionally treat metabolically unstable or active atherosclerotic plaque. The process involves administering an intravenous solution containing a radioactive tracer that specifically accumulates in these plaques. A miniaturized radiation detector is then applied directly within the arterial lumen to identify and differentiate active, unstable plaque from inactive, stable plaque. The treatment options include mechanical expansion of the vessel, mechanical ablation of the plaque, or delivering a metabolism-altering agent to the affected site.

Career Highlights

Robert J Lederman is affiliated with the University of Michigan, where he continues to advance research in medical imaging and treatment technologies. His work has garnered attention for its potential to revolutionize how atherosclerosis is diagnosed and treated.

Collaborations

Lederman collaborates with Richard L Wahl, a fellow expert in the field, to further enhance the development and application of his patented technologies.

Conclusion

Robert J Lederman's innovative methods for detecting atherosclerosis represent a significant advancement in medical technology. His contributions have the potential to improve diagnostic accuracy and treatment options for patients suffering from vascular diseases.